Melatonin increases the expression of insulin-like growth factor I in rats with carbontetrachlorid-induced hepatic damage

Journal of Animal and Veterinary Advances

Volumn 8, Issue 11, 2009, Pages 2256-2261

  Oner, Jale ^a   Kus, Ilter ^b   Oner, Hakan ^a  

^a MEHMET AKIF ERSOY UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

Carbon tetrachloride; Hepatotoxicity; IGF I; Immunohistochemistry; Melatonin; Rat

Indexed keywords

EID: 77951627960     PISSN: 16805593     EISSN: 1993601X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Castilla-Cortazar, I, J. Prieto and E. Urdaneta, 1997a. Impaired intestinal sugar transport in cirrhotic rats: Correction by low doses of insulinlike growth factor I. Gastroenterology, 113: 1180-1187. DOI: http://dx.doi.org/10.1053/gast.1997.vll3.pm 9322513. http://www.sciencedirect.com/science?_ ob=ArticleURL&_udi=B6WFX-4C53I6K45&_user= 6667097 &_rdoc=l&_fmt=&_orig=search&_sort=d&_ docanchor=&view=c&_acct=C000067391&_version= l&_urlVersion=0&_userid=6667097&md5=b3d3753 0debad906b3595c56a68395cl.
2. Castilla-Cortazar, I., M. Garcia and B. Muguerza et al, 1997b. Hepatoprotective effects of insulin-like growth factor-I in rats with carbon-tetrachloride-induced cirrhosis. Gastroenterology, 113: 1682-1691. DOI: 10.1053/gast.l997.vll3. PMTD: 9352873. http://www.sciencedirect. com/science ?_ob=Article URL&_udi=B6WFX-4C53ITKI4&_user=6667097 &_rdoc=l&_fmt=&_orig=search&_sort=d&_doca nchor=&view=c&_acct=C000067391 &_version= 1 &_ urlVersion=0&_usend=6667097&md5=3fcbe513b32f e2e5f2a8c502aa92385c.
3. Castilla-Cortazar, I., A. Picardi and J. Ainzua et al., 1999. Effect of insulin-like growth factor I on in vivo intestinal absorption in cirrhotic rats. Am. J. Physiol., 276: G637-G642. PMID: 9886976. http://ajpgi.physiology.org/cgi/content/full/276/1/G37.
4. Castilla-Cortazar, I., M.A. Aliaga-Montilla and J. Salvador et al, 2001. Insulin-like growth factor-I restores the reduced somatostatinergic tone controlling growth hormone secretion in cirrhotic rats. Liver, 21: 405-409. DOI: 10.1034/j.l 600-0676.2001.210607.http://www3.mterscience.wiley.com/cgibin/fulltext/120098158/PDFSTART.
5. Caufriez, A., P. Reding, D. Urbain, J. Goldstein and G. Copinschi, 1991. Insulin like growth factor-I: A good indicator of functional hepatocelular capacity in alcoholic liver cirrhosis. J. Endocrinol. Invest., 14: 317-321. PMID: 1865082.
6. Cemborain, A., I. Castilla-Cortazar and M. Garcia et al., 1998. Osteopenia in rats with liver cirrhosis: Beneficial effects of IGF-I treatment. J. Hepatol., 28: 122-131. PMID: 9537849 http://www.ncbi.nlm.nih.gov/pub-med/9537849?ordinalpos=2&itool=EntrezSystem2.P Entrez.Pubmed.Pubmed_ResultsPanel.Pubmed_ DefaultReportPanel.Pubmed_RVDocSum.
7. Conchillo, M., J. Prieto and J. Quiroga, 2007. Insulin-like Growth Factor I (IGF-I) and liver cirrhosis. Rev. Esp. Enferm. Dig., 99: 156-164. PMID: 17516829. http://www.grupoaran.com/mrmUpdate/lecturaPDFf romXML. asp?IdArt=458749&TO=RVN&Eng=l.
8. Fan, I., P.E. Molina, M.C. Gelato and C.H. Lang, 1994. Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin. Endocrinology, 134: 1685-1692. PMID: 7511091.
9. Friedman, S.L., 2000. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem., 275: 2247-2250.PMID: 10644669. http://www.jbe.org/cgi/content/full/275/4/2247?view=long.
10. Garcia-Fernandez, M., I. Castilla-Cortazar and M. Diaz-Sanchez et al, 2005. Antioxidant effects of insulin-like Growth Factor-I (IGF-I) in rats with advanced liver cirrhosis. BMC Gastroenterol, 5: 1-8. DOI: 10.1186/ 1471-230X-5-7.PMID: 15745444. http://www.biomedcentral,com/1471-230X/5/7.
11. Hattori, N., H. Kurahachi and K. Ikekubo et al, 1992. Serum growth hormone-binding protein, insulin-like growth factor-I and growth hormone in patients with liver cirrhosis. Metabolism, 41: 377-381. DOI: 10.1016/ 0026-0495(92)90071-H. http://www.sciencedirect.coiiiscience?_ob=ArticleURL&_udi=B6WN4-4C2S CCM1 RS&_user=6667097&_rdoc=l &_fint=&_ong= search&_sort=d&_doc anchor=&view=c&_acct= CO 00067391&_version=l&_urlVersion=0&_userid=6667097&md5=b219a2e852be7e3272a60af5efb26e45.
12. Inoue, T., H. Honai, C. Aoki, I. Kawamura, M. Ota, H. Mizuhara, M. Tomoi and S. Mutoh, 2003. Insulin-like growth factor-I prevents lethal acute liver failure induced by D-galactosamine and lipopolysaccharide mrats. In vivo, 17: 293-299. PMID: 12929583.
13. Kus, I, M. Ogeturk, H. Oner, S. Sahin, H. Yekeler and M. Sarsilmaz, 2005. Protective effects of melatonin against carbon tetrachloride-induced hepatotoxicity in rats: A light microscopic and biochemical study. CellBiochem. Funct., 23: 169-174
14. Lang, C.H., V. Pollard and J. Fan et al., 1997. Acute alterations in growth hormone-insulin-like growth factor axis in humans injected with endotoxin. Am. J. Physiol. Regul Integr. Comp. Physiol., 273: R371-R378. PMID: 9249574.
15. Mirpuri, E.,E.R. Garcia-Trevijano and I. Castilla-Cortazar et al., 2002. Altered liver gene expression in CC14-cirrhotic rats is partially normalized by insulin-like growth factor-I. Int. J. Biochem. Cell. Biol., 34: 242-252. DOI: 10.1016/S1357-2725(01)00123-6. PMID: 11849991. http://www.sciencedirectcom/science?_ob=ArticleURL&_udi=B6TCH-448FP901&_user=6667097&_rdoc=l&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000067391&_version=l&_urlVersion=0&_userid=6667097&rnd5=af2c20b33e2a61a8d81f8a648fdd0259.
16. Moller, S., U. Becker, A. Juul, N.E. Skakkebask and E. Christensen, 1996. Prognostic value of insulin-like growth factor-I and its binding proteins in patients with alcohol-induced liver disease. Hepatology, 23: 1073-1078. DOI: 10.1002/hep. 510230521. PMID: 8621136. http://www3.interscience.wiley.com/cgi bin/fulltext/106593984/PDFSTART.
17. Muguerza, B., I. Castilla-Cortazar, M. Garcia, J. Quiroga, S. Santidrian and J. Prieto, 2001. Antifibrogenic effect in vivo of low doses of insulin-like growth factor-I in cirrhotic rats. Biochim. Biophys. Acta, 1536: 185-195. DOI: 10.1016/S0925-4439(01)00045-X.PMTD: 114063 53. http://www.sciencedirectcom/science?_ob=ArticleURL&_udi=B6TlY4378X3Y&_user=6667097&_rdoc=l&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000067391&_version=1&_urlVersion=0&_userid=6667097&md5=3fe56819ba20cd270b8e910ce8df479f.
18. Oner, J. andE. Ozan, 2003. Effects of melatomn on skeletal muscle of rats with experimental hyperthyroidism. Endocr. Res., 29: 445-455. PMID: 14682473.
19. Ostrowska, Z., B. Kos-Kudla, E. Swietochowska, B. Marek, D. Kajdaniuk and N. Ciesielska-Kopacz, 2001. Influence of pinealectomy and long-term melatomn administration on GH IGF-I axis function in male rats. Neuroendocrinol. Lett., 22: 255-262. PMID: 11524633.
20. Ostrowska, Z., B. Kos-Kudla and M. Nowak etal, 2003. The relationship between bone metabolism, melatonin and other hormones in sham-opareted and pmealectomized rats. Endocr. Regu., 37: 211-224. PMID: 15106818.
21. Pascual, M., I. Castilla-Cortazar and E. Urdaneta et al., 2000. Altered intestinal transport of amino acids in cirrhotic rats: The effect of insulin-like growth factor-I. Am. J. Physiol. Gastrointest Liver Physiol., 279: 319-324. PMID: 10915640. http://ajpgi.physiology.org/cgi/content/full/279/2/G319.
22. Pawlikowski, M., M. Kolomecka, A. Wojtczak and M. Karasek, 2002. Effects of six months melatonin treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate and somatomedm C in elderly women. Neuroendocrinol. Lett., 23: 17-19. PMID: 12019346.
23. Picardi, A., A.C. De Oliveira and B. Muguerza et al., 1997. Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis. J. Hepatol., 26: 191-202. DOI: 10.1016/ S0168-8278(97)80026-8. PMID: 9148011. http://www. sciencedirect.com/ science?_ob=ArticleURL&_udi= B6W7C-44FMNX DW1 &_user=6667097&_rdoc=l &_ fmt=&_orig=search&_sort=d&_docanchor=&view= c&_acct=C000067391 &_version=l &_urlVersion=0 &_userid=6667097&md5=95518b9d7b0f8eeddd2de3 99fO168f77.
24. Pinzani, M., H.E. AbboudandD.C. Aron, 1990. Secretion of insulin-like growth factor-I and binding proteins by rat liver fat-storing cells: Regulatory role of platelet-derived growth factor. Endocrinology, 127: 2343-2349. PMID: 1699746.
25. Reiter, R.J., 1994. Pineal function during aging: Attenuation of the melatonin rhythm and its neurobiological consequences. ActaNeurobiol. Exp., 54: 31-39. PMID: 7801790.
26. Sanz, S., J.B. Pucilowska, S. Liu and CM. Rodri Guez-Ortigosa etal., 2005. Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury. Gut., 54: 134-141. DOI: 10.1136/gut.2003. 024505. PMID: 15591519. http://www.pubmedcentral. nih.gov/articlerender. fcgi?tool=pubmed&pubmedid= 15591519.
27. Schaeffer, H.J. and A.V. Sirotkin, 1997. Melatonin and serotonin regulate the release of insulin-like growth factor-I, oxitocin and progesterone by cultured human granulosa cells. Exp. Clin. Endocrinol. Diabetes, 105: 109-112. PMID: 9137942.
28. Scharf, J.G., F. Dombrowski, R. Novosyadlyy, C. Eisenbach, I. Demon, B. Kubler and T. Braulke, 2004. Insulin-like Growth Factor (IGF)-binding protein-1 is highly induced during acute carbon tetrachloride liver injury and potentiates the IGF-I-stimulated activation of rat hepatic stellate cells. Endocrinology, 145: 3463-3472. DOI: 10.1210/en. 2003-1541. PMID: 15070850. http://endo.endojournals.org/cgi/content/full/145/7/3463.
29. Seval, Y., G. Akkoyunlu, R. Demir and M. Asar, 2004. Distribution patterns of Matrix Metalloproteinase (MMP)-2 and -9 and their inhibitors (TIMP-1 and TIMP-2) in the human decidua during early pregnancy. Acta Histochem, 106: 353-362. PMID: 15530550
30. Soto, L., A.I. Marti'n, S. Milla'n, E. Vara and A. Lo'pez-Caldero'n, 1998. Effects of endotoxin lipopolysaccharide administration on the somatotropic axis. J. Endocnnol., 159: 239-246. PMID: 9795364. http://joe.endocrinology-journals.org/cgi/reprmt/159/2/239.
31. Svegliati-Baroni, G.,F. Ridolfiand A. Di Sario etal, 1999. Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: Differential effects on signal transduction pathways. Hepatology, 29:1743-1751.DOI: 10.1002/hep.510290632. PMTD: 103 47117. http://www3.inters cience.wiley.com/cgi-bin/fulltext/106596372/PDFSTART.
32. Vaughan, M.K., G.R. Buzzell, R.A. Hoffman, A. Menendez Pelaez and R.J. Reiter, 1994. Insulm-hke growth factor-1 in Syrian hamsters: Interactions of photopenod, gonadal steroids, pmealectomy and continious melatonin treatment. Proc. Soc. Exp. Biol. Med., 205: 327-331. PMID: 8171056.
33. Vriend, I., M.S. Sheppard and K.T. Borer, 1990. Melatonin increases serum growth hormone and Insuline-like Growth Factor I (IGF-I) levels in male Syrian hamsters via hypothalamic neurotransmitters. Growth Dev. Aging., 54: 165-171. PMID: 1709150.
34. Wang, H., W. WeitandN.P. Wang et al, 2005. Melatonin ameliorates carbon tetrachloride-induced hepatic fibrogenesis in rats via inhibition of oxidative stres. Life Sci., 77: 1902-1915. DOI: http://dx.doi.org/10. 1016/j.lfs.2005.04.013. PMID: 15925388. http://www. sciencedirect. com/science ?_ob=ArticleURL&_udi= B6T99-4G94IlI-3&_user=6667097&_rdoc=l&_ fmt=&_orig=search&_sort=d&_docanchor=&view= c&_acct=C000067391 &_version=l &_urlVersion=0 &_userid=6667097&md5=4665c5b9235ele091320e 7856c20f723